H2020Индивидуална стипендия2021–2024

EBAP · Evidence-Based Assessment in Psychotherapy (EBAP) Study

„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“

Период: 2021-10-01 → 2024-10-07
Финансиране от ЕС: 263 732 €
Участници: 3
Схема: MSCA-IF

Линиите свързват координатора с партньорите.

Накратко на български

Психотерапевтичните процеси се анализират чрез съчетаване на обективни измервания с емоционалната връзка между пациента и терапевта. Такъв подход помага за по-добро проследяване на прогреса и подобряване на резултатите от лечението на психични разстройства.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Evidence-Based Assessment in Psychotherapy (EBAP) Study

Mental disorders (MDs) affect about one-tenth of the world’s population and are among the leading causes of years lived with disability. Currently, pharmacotherapy represents the first-line option in most settings in Europe and North America, but growing evidence suggests that although it is effective in the treatment of acute episodes, medication alone does not help many patients to achieve a functional recovery or to prevent mental illness (e.g., for individuals at clinical high risk of psychosis or self-injury). Psychotherapies can produce behavior and lifestyle changes essential to relapse prevention, long-term maintenance, and promoting positive function. At present, MD treatment remains, to a large extent, a “subjective clinical exercise.” Therefore, implementing evidence-based assessment (EBA) for MDs is essential to reduce their burden at individual, societal, and public health levels: using it to monitor psychotherapy processes and to evaluate progress can increase patient engagement and enhance therapy outcomes. However, to be fully effective, the EBA algorithms should be “humanized” because psychotherapeutic processes take place inside the patient-clinician relationship. This study will (1) develop a battery for individual psychotherapy that (a) combines EBA with measures of key elements of the therapeutic relationship (TR) (i.e., therapeutic alliance, and patient/therapist’s in-session feelings toward each other) and (b) is valid and easy enough to be administered routinely in real-world psychotherapeutic settings. Integrating measures of the TR brings back humanistic and emotional dynamics to the treatment process. It also adds sophisticated ways of thinking about the TR and its association with treatment outcomes, which are produced by a complex human relationship. The combination prevents EBA from being merely an algorithm; (2) roll out the EBA approach in real-world psychotherapeutic settings to investigate (randomized controlled clinical trial) how it affects psychotherapy process and outcome; (3) disseminate/notify the results to both academic and clinical communities.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

Mood disorders (MDs) affect more than 300 million people. They are the third leading causes in 2017 of years lived with disability. Currently, pharmacotherapy represents the first-line option, but growing evidence suggests that although it is effective in the treatment of acute episodes, medication alone does not help many patients to achieve a functional recovery. However, despite it being established that psychotherapies are effective in treating MDs, there is still much to improve in our understanding, management, and treatment of MDs. Waiting for progress in personalized psychiatric treatment approaches that could lead to precise biological and psychosocial interventions, the treatment of MDs remained, to a large extent, “subjective clinical exercise.” Implementing evidence-based assessment (EBA) and treatment for MD is essential to reduce their burden at an individual, societal and public health levels. An efficient assessment process is essential because it leads to more accurate diagnosis, better treatment matching, increased patient engagement, and enhanced outcomes. When deciding how to conduct such EBA, the clinician has to consider the target content for the assessment, the function that the assessment could serve in the treatment context, and the different candidate assessments available. This project has three main goals: (1) to develop and evaluate (pilot study) an EBA approach to individual psychotherapy that is valid and easy enough to be administered routinely in real-world psychotherapeutic settings; (2) to roll out the EBA approach in real-world psychotherapeutic settings to investigate (randomised controlled clinical trial) how it affects psychotherapy process and outcome; (3) to disseminate/notify the project study results to both academic and clinical communities. By combining sophisticated models of therapeutic process (Contextual and Quadripartite Models) with EBA, we expect to show increases in rapport, fewer ruptures and premature treatment

Оригинален текст от CORDIS (на английски).

Участници

UNIVERSITA DEGLI STUDI DI PAVIA · PaviaКоординаторИталия
FUNDACIO DE RECERCA CLINIC BARCELONA-INSTITUT D INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER · BarcelonaИспания
THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL · Chapel HillСъединени щати